BioStem Technologies, Inc. Common Stock BSEM

$4.40 -7.17% at last close
Market Cap$84.52 million
P/E Ratio—
Div Yield—
Volume237.7K
52-Week Range $2.25$8.40

Key Stats

Today's Range
$4.40 – $5.25
50-Day Range
$2.25 – $5.44
52-Week Range
$2.25 – $8.40
Volume
238K shs
Average Volume
155K shs
Market Cap
$84.52 million
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
0.00%
Days to Cover
1.00

About BioStem Technologies, Inc. Common Stock

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
2
Exchange
XNAS
Listed
2008-10-31

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.